Planning

Risk and Safety Communications Project - Early Market Engagement and RFI

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY

This public procurement record has 1 release in its history.

Planning

21 Aug 2024 at 20:06

Market Engagement Notice
Summary of the contracting process

The Medicines and Healthcare Products Regulatory Agency (MHRA) is currently in the planning stage of a procurement process titled "Risk and Safety Communications Project - Early Market Engagement and RFI." This procurement pertains to the marketing services industry, as classified under CPV Code 79342000, and aims to enhance the agency's communication strategies. The procurement process is scheduled to end its engagement phase on 16th September 2024. The MHRA is located in London, with a postal code of E14 4PU, and seeks to engage suppliers who can deliver communication services across the United Kingdom and other specified regions.

This tender presents significant opportunities for businesses specialising in marketing services, especially those with experience in risk and safety communications within the healthcare sector. The MHRA is looking for suppliers who can provide an up-to-date, actively maintained UK-wide database of healthcare professionals and administrative staff to facilitate timely information dissemination. This opportunity is particularly suited for SMEs with a successful track record in similar projects or communications campaigns, offering a potential contract value of £200,000. Interested businesses are encouraged to utilise this early market engagement phase to understand the requirements better and position themselves effectively for the forthcoming formal procurement process.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Risk and Safety Communications Project - Early Market Engagement and RFI

Notice Description

Risk and safety communication is a critical part of the Medicines Healthcare products Regulatory Agency (MHRA)'s work, with the potential for a major and immediate impact on public health and safety, and consequently our corporate reputation. It is essential therefore that we issue effective communications via appropriate channels to relevant audiences to support patient safety and public health. The MHRA's current risk and safety communication approaches have been in place for many years, and while there have been some enhancements over time, this is the first major strategy review we have undertaken to help inform the future of risk and safety communications work across the MHRA. The MHRA needs to reach as many HCPs as possible, across all four nations in the UK, and across all sectors of health and care. The objective of any proposed procurement competition(s) will be to award a contract to one or more suppliers who can deliver the services of facilitating communication with an up-to-date, actively maintained, UK-wide list/database of healthcare professionals and relevant administrative staff (may also include other organisation representatives), to enable the MHRA to issue information in a timely and quick manner to a very large audience. We would be looking for demonstrable experience and success at conducting similar projects or communications campaigns. The MHRA is conducting this early market engagement activity to explore potential solutions that could meet the requirements set out in our brief for delivery by one or more suppliers (numbers and approach to be agreed). This engagement is also intended to alert interested organisations/potential suppliers to our project and provide the opportunity to gain an understanding of and comment on our proposed requirements, as well as to gauge and garner market interest. This early market engagement activity does not form part of a formal procurement process. For further information, please go onto our e-procurement portal/system Atamis (https://health-family.force.com/s/Welcome) to see the full Brief and RFI document ref C302172.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-25fb5ab9-b5bf-4450-9725-bc405f708916
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/30622ee1-5d78-4825-bf27-92cd8b17c2a1
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79342000 - Marketing services

Notice Value(s)

Tender Value
£200,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
21 Aug 20241 years ago
Submission Deadline
Not specified
Future Notice Date
16 Sep 2024Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-25fb5ab9-b5bf-4450-9725-bc405f708916-2024-08-21T21:06:47+01:00",
    "date": "2024-08-21T21:06:47+01:00",
    "ocid": "ocds-b5fd17-25fb5ab9-b5bf-4450-9725-bc405f708916",
    "language": "en",
    "initiationType": "tender",
    "title": "Risk and Safety Communications Project - Early Market Engagement and RFI",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2024-09-16T23:59:59+01:00"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/30622ee1-5d78-4825-bf27-92cd8b17c2a1",
                "datePublished": "2024-08-21T21:06:47+01:00",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "description": "C302172 Risk and Safety Communications Early Market Engagement Brief and RFI Questionnaire - final",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/c00a00cf-d59c-4ce5-a79d-5b9b62285401",
                "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
            }
        ]
    },
    "tender": {
        "id": "CF-2555300D0O000000rwimUAA",
        "title": "Risk and Safety Communications Project - Early Market Engagement and RFI",
        "description": "Risk and safety communication is a critical part of the Medicines Healthcare products Regulatory Agency (MHRA)'s work, with the potential for a major and immediate impact on public health and safety, and consequently our corporate reputation. It is essential therefore that we issue effective communications via appropriate channels to relevant audiences to support patient safety and public health. The MHRA's current risk and safety communication approaches have been in place for many years, and while there have been some enhancements over time, this is the first major strategy review we have undertaken to help inform the future of risk and safety communications work across the MHRA. The MHRA needs to reach as many HCPs as possible, across all four nations in the UK, and across all sectors of health and care. The objective of any proposed procurement competition(s) will be to award a contract to one or more suppliers who can deliver the services of facilitating communication with an up-to-date, actively maintained, UK-wide list/database of healthcare professionals and relevant administrative staff (may also include other organisation representatives), to enable the MHRA to issue information in a timely and quick manner to a very large audience. We would be looking for demonstrable experience and success at conducting similar projects or communications campaigns. The MHRA is conducting this early market engagement activity to explore potential solutions that could meet the requirements set out in our brief for delivery by one or more suppliers (numbers and approach to be agreed). This engagement is also intended to alert interested organisations/potential suppliers to our project and provide the opportunity to gain an understanding of and comment on our proposed requirements, as well as to gauge and garner market interest. This early market engagement activity does not form part of a formal procurement process. For further information, please go onto our e-procurement portal/system Atamis (https://health-family.force.com/s/Welcome) to see the full Brief and RFI document ref C302172.",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "79342000",
            "description": "Marketing services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "E14 4PU"
                    },
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 200000,
            "currency": "GBP"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-231694",
            "name": "Medicines and Healthcare Products Regulatory Agency",
            "identifier": {
                "legalName": "Medicines and Healthcare Products Regulatory Agency"
            },
            "address": {
                "streetAddress": "10 South Colonnade, Canary Wharf",
                "locality": "London",
                "postalCode": "E14 4PU",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Purchasing",
                "email": "purchasing@mhra.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-231694",
        "name": "Medicines and Healthcare Products Regulatory Agency"
    }
}